Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
April 30, 2026 -26.66%
January 31, 2026 -1.01K%
October 31, 2025 -399.8%
July 31, 2025 -510.3%
April 30, 2025 -387.8%
January 31, 2025 -349.1%
October 31, 2024 -423.7%
July 31, 2024 -535.7%
April 30, 2024 -239.4%
January 31, 2024 -100.9%
October 31, 2023 -141.4%
July 31, 2023 -529.8%
April 30, 2023 -130.7%
January 31, 2023 -65.34%
October 31, 2022 -119.7%
July 31, 2022 -9.41%
April 30, 2022 -43.66%
January 31, 2022 -64.97%
October 31, 2021 -62.07%
July 31, 2021 -291.2%
April 30, 2021 -241.5%
January 31, 2021 -23.69%
October 31, 2020 68.62%
July 31, 2020 22.05%
April 30, 2020 -76.03%
Date Value
January 31, 2020 -88.84%
October 31, 2019 -83.50%
July 31, 2019 -8.69%
April 30, 2019 30.54%
January 31, 2019 -16.00%
October 31, 2018 15.60%
July 31, 2018 35.72%
April 30, 2018 -7.72%
January 31, 2018 -3.59%
October 31, 2017 -18.81%
July 31, 2017 -38.28%
April 30, 2017 -19.42%
January 31, 2017 -35.23%
October 31, 2016 -34.59%
July 31, 2016 12.88%
April 30, 2016 -11.15%
January 31, 2016 80.24%
October 31, 2015 84.95%
July 31, 2015 18.85%
April 30, 2015 78.81%
January 31, 2015 54.84%
October 31, 2014 53.38%
July 31, 2014 83.56%
April 30, 2014 12.70%
January 31, 2014 0.58%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
MedX Health Corp. 27.96%
VentriPoint Diagnostics Ltd. -258.1%
Theralase Technologies, Inc. 21.12%
Profound Medical Corp. 78.41%
VVT Med, Inc. 45.51%

Gross Profit Margin (Quarterly) Related Metrics